|
 |
SynviscThis page contains recent news articles, when available, and an overview of Synvisc but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.But he played through pain, played through multiple shots of Synvisc, and produced at the plate when he was in the lineup, driving in 75 runs and compiling ... Boston Herald (blog) GRAHAM v. HARTFORD LIFE & ACCIDENT INSURANCE COMPANY - Dec 30, 2009 On January 11, 2000, Dr. Emel reported to the OWCP that the Synvisc injections provided "good relief;" by that point, Graham had "no swelling and actually ... Leagle, Inc. Genzyme Corporation Q3 2009 Earnings Call Transcript - Oct 21, 2009 Synvisc-One is on a very strong start. The franchise is up 30% versus last year, about 50% of the revenues now come from Synvisc-One, that's about six ... Seeking Alpha (blog) Genzyme Releases 3Q Financial Results - Oct 26, 2009 Genzyme currently has offices in Beijing and Shanghai, and markets Synvisc, Thymoglobulin and Fludara in China. In addition, Genzyme is building its ... Trading Markets (press release) Genzyme Q3 profit falls more than expected - Oct 21, 2009 Those losses were offset to some extent by strong sales of its osteoarthritis product Synvisc-One, whose sales rose 30 per cent to $US87.5 million. ... Business Spectator (registration) Genzyme 盈餘低於é ?期，股價下跌4% - Oct 21, 2009 ...é ?期1.8憶美元；Fabrazyme銷售é¡?1.152æ†¶ç¾Žå…ƒï¼Œå¸‚å ´é ?期1.14億美元；Myozyme銷售é¡?8600è?¬ç¾Žå…ƒï¼Œå¸‚å ´é ?期8800è?¬ç¾Žå…ƒã€‚Synvisc銷售é¡?8750è?¬ç¾Žå…ƒï¼Œå¸‚å ´é ?期8300è?¬ç¾Žå…ƒã€‚ 環球財經 Genzyme 盈馀低於预期，股价下跌4% - Oct 21, 2009 SynvISc销售é¢?8750万美元，市场预期8300万美元。 å…?è´£å£°æ˜Žï¼šæœ¬æ–‡ä»…ä»£è¡¨ä½œè€…ä¸ªäººè§‚ç‚¹ï¼Œä¸Žå‡¤å‡°ç½‘æ— å…³ã€‚å…¶åŽŸåˆ›æ€§ä»¥å?Šæ–‡ä¸é™ˆè¿°æ–‡å—和内容未ç»?本站è¯?实，对本文以å?Šå…¶ä¸å…¨éƒ¨ ... 凤凰网 세계 ì œë„¤ë¦ì‚¬ ë°”ì?´ì˜¤ì‹œë°€ëŸ¬ 개발 활발 - Oct 20, 2009 ...ì„¸ë ˆìž?ìž„'(Cerezyme, imiglucerase), 'ì‹ ë¹„ìŠ¤í?¬'(Synvisc, hylan GF 20), '파브ë?¼ìž?ìž„'(Fabrazyme, agalsidase beta) 등ì?˜ 특허가 모ë‘? 만료ë? ì „ë§?ì?´ë‹¤. 디지틀보사 Genzyme receives European CE Mark approval for Synvisc-One - Dec 19, 2007 NEW YORK (Thomson Financial) - Genzyme Corp. Wednesday received a European CE Mark of approval for Synvisc-One, the single treatment of Synvisc that has ... Forbes Genzyme's Synvisc retains high reimbursement rate - Dec 15, 2006 NEW YORK (Reuters) - Genzyme Corp. (GENZ.O) said on Friday its osteoarthritis pain treatment Synvisc will retain a separate, higher reimbursement rate, ... Washington Post FDA asks Genzyme for more data on Synvisc-One - Nov 13, 2007 LOS ANGELES, Nov 13 (Reuters) - Biotechnology company Genzyme Corp (GENZ.O) said on Tuesday that US regulators requested additional analyses and data ... Reuters Synvisc to Keep Medicare Code - Nov 8, 2005 By TSC Staff. Genzyme (GENZ - commentary - Cramer's Take) said Synvisc, its product used to treat pain associated with osteoarthritis of the knee, ... TheStreet.com - TheStreet.com (subscription) US advisers back Genzyme therapy for knee pain - Dec 9, 2008 The older Synvisc is given via three injections, each one week apart. ... Synvisc-One contains a fluid made with hyaluronic acid extracted from chicken ... Reuters Label Expanded for Synvisc - Oct 2, 2006 Genzyme(GENZ Quote) received European regulatory approval for its joint pain drug Synvisc for treating osteoarthritis of the ankle and shoulder. ... TheStreet.com - TheStreet.com (subscription) Genzyme seeks new Synvisc use - Jun 20, 2007 Genzyme Corp., a Cambridge biotechnology company, said today that it is seeking regulatory approval to use its Synvisc pain treatment in a new way. ... Boston Globe US FDA questions Genzyme knee pain treatment study - Dec 5, 2008 The study showed a 'statistically significant' reduction of pain in patients given the treatment, called Synvisc-One, but FDA staff raised questions about ... Forbes Genzyme asks European regulators for broader use of Synvisc - Aug 11, 2006 Biotechnology giant Genzyme Corp. has petitioned European regulators to broaden the application of its Synvisc pain killer to treat patients with ... Bizjournals.com Wells placed back on the DL - Apr 16, 2006 And that, according to medical experts familiar with Synvisc, doesn't bode well. Synvisc is artificial joint lubricant, used in the absence of sufficient ... Boston Globe Genzyme's hylastan misses goal in arthritis trial - Jul 5, 2007 Synvisc-One is a combined-dose regimen of Synvisc, designed to be given as a single injection, as opposed to the three-injection course required with ... Reuters Genzyme expects FDA ruling on Myozyme - Sep 23, 2008 16, and it expects a ruling on Synvisc-One by Dec. 23. ... Synvisc-One is intended to treat ostheoarthritis of the knee, and combines three older drugs into ... Boston Globe Genzyme Completes Purchase of Synvisc Sales and Marketing Rights - Jun 1, 2005 CAMBRIDGE, Mass., Jan. 6 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that it has completed the transaction to buy back the sales and marketing ... Euro am Sonntag Genzyme profits leap 58 percent in second quarter. - Jul 15, 2005 Synvisc, an artificial knee fluid, was developed by a company called Biomatrix that Genzyme auired in 2000. Renagel, which helps reduce phosphate buildup in ... Free with registration - Boston Globe - AccessMyLibrary.com Closer strikes out side in first exhibition game - Mar 24, 2006 ...faced but must overcome his late start as he came back from the surgeries and had three recent injections in each knee of the joint lubricant Synvisc. ... ESPN Genzyme files for FDA approval of single-treatment Synvisc-One - Jun 23, 2007 Genzyme Corp. has announced that it has filed with the US Food and Drug Administration (FDA) for approval of Synvisc-One, the single treatment of Synvisc ... News-Medical.net Genzyme Blows Past Forecasts - Oct 18, 2005 Sales of the knee-pain treatment Synvisc more than doubled to $57.7 million after the company acquired sales rights for the drug in the US and five European ... TheStreet.com - TheStreet.com (subscription) Osteoarthritis - Symptoms, Diagnosis, Treatment of Osteoarthritis -... - May 5, 2008 Artificial joint fluid (Synvisc, Hyalgan). These medications can be injected into the knee. They may relieve pain for up to 6 months. ... New York Times … Demonstrates One Administration of Synvisc Improves Osteoarthritis... - Nov 30, 2006 CAMBRIDGE, Mass., Nov. 30 /PRNewswire-FirstCall/ -- Genzyme Corporation announced today that preliminary results from a new study indicate that patients ... RedOrbit FDA Advisory Committee to Discuss Genzyme's Synvisc-One PMA on … - May 12, 2008 Genzyme Corporation (Nasdaq: GENZ) today announced that its Premarket Approval (PMA) application supplement for Synvisc-One â„¢ (hylan GF 20) will be ... FINANZEN.NET NEWS - FINANZEN.NET NEWS Genzyme's Near-Term Growth Seen Driven By Renagel - Apr 20, 2006 The shortfall was attributed to weaker sales of arthritis drug Synvisc, Fabrazyme, a treatment for a rare disorder known as Fabry disease, and Hectorol, ... Forbes Genzyme diarrhea drug fails large test - Jul 7, 2007 As a result, Genzyme said it was mothballing the hylastan program, and will focus on Synvisc-One, a different injection for knee pain. ... Boston Globe Genzyme to challenge Synvisc rate - Oct 30, 2006 Genzyme Corp. will challenge federal reimbursement rates for its osteoarthritis treatment because it says current levels are below market price and could ... San Antonio Business Journal Genzyme completes purchase of Synvisc sales and marketing rights. - Jan 6, 2005 Genzyme Corp has completed the transaction to buy back the sales and marketing rights to Synvisc (hylan GF 20) in the US and five European countries from ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Genzyme Files for Approval of Single-Treatment Synvisc-Oneâ„¢ - Jun 26, 2007 Genzyme Corp. (Nasdaq: GENZ) announced today that it has filed with the US Food and Drug Administration (FDA) for approval of Synvisc-Oneâ„¢, ... webwire.com Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief … - Oct 22, 2008 CAMBRIDGE, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Genzyme Corporation has announced findings from an independent study which investigated effectiveness ... RedOrbit … Release: Genzyme Completes Purchase of Synvisc Sales and Marketing... - Jan 6, 2005 Genzyme Completes Purchase of Synvisc Sales and Marketing Rights. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research FOULKE: I'LL BE CLOSING AT THE START - Mar 19, 2006 He has been receiving injections of Synvisc, a lubricant administered over a three-week period that Foulke said works like WD-40 for both knees. ... Pay-Per-View - Hartford Courant - ProQuest Archiver SYNVISC IMPROVES OSTEOARTHRITIS PAIN. - Jan 1, 2007 Genzyme Corporation (NASDAQ:GENZ), Cambridge, Mass. has announced that preliminary results from a new study indicate that patients using Synvisc (hylan GF ... Entrepreneur Judge approves shareholder suit against Genzyme - The Boston Globe - Aug 17, 2006 ...the division's biggest product, Synvisc , which is used to treat arthritis; positive news about recent Synvisc sales; and the fact that two companies ... Boston Globe Positive Synvisc Data Published by Cochrane Collaboration. - May 5, 2005 CAMBRIDGE, Mass., May 5 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that a lengthy review examining the clinical benefits of Synvisc(R) (hylan ... $4.95 - PR Newswire - ECNext … Receives European CE Mark for Single-Treatment Synvisc-One(TM). -... - Dec 19, 2007 Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Genzyme Sticks With Forecast - Feb 15, 2006 Synvisc sales are projected to be $255 million to $265 million this year vs. $219 million this past year. Meanwhile, Genzyme believes revenue for its ... TheStreet.com - TheStreet.com (subscription) Press Release: Independent Study Reveals SYNVISC(R) Offers Longer … - Oct 22, 2008 Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee. Pay-Per-View - PR Newswire - HighBeam Research Acute Local Reaction toIntra-Articular Hylan GF 20 (Synvisc): Part II - May 1, 2005 David D. Waddell, MD, Seth S. Leopold, MD, Winston J. Warme, LTC (P), MD, Patrick D. Pettis, LVN and Susan Shott, PhD. Corresponding author (letter): David ... Journal of Bone and Joint Surgery - Journal of Bone and Joint Surgery... … : Genzyme Files for Approval of Single-Treatment Synvisc-One(TM). -... - Jun 20, 2007 Genzyme Files for Approval of Single-Treatment Synvisc-One(TM). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Positive Synvisc Data Presented at European Conference - Jun 26, 2006 CAMBRIDGE, MA -- June 26, 2006 -- Genzyme Corp. (Nasdaq: GENZ) today announced that data were presented from an independent clinical study examining the ... DG News Genzyme buys back marketing rights for Synvisc - Jan 7, 2005 Genzyme Corp. has completed its repurchase of the selling and marketing rights for its anti-inflammatory drug Synvisc, a popular treatment for ... Boston Business Journal International Approvals: Januvia, Synvisc-One, Eloxatin - Jan 29, 2008 January 29, 2008 — The European Commission (EC) has approved sitagliptin tablets for use as add-on therapy to a sulfonylurea both with and without metformin ... Medscape GENZYME FILES FOR EUROPEAN APPROVAL OF SYNVISC. - Sep 1, 2006 Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass., has filed with the European authority to expand the CE mark for Synvisc(R) (hylan GF 20) to include treatment ... Entrepreneur Genzyme's Synvisc retains Medicare status.(reimbursement code and … - Nov 21, 2005 Cambridge, Massachusetts, USA-headquartered biotechnology firm Genzyme says that Synvisc (hylan GF-20), a viscosupplement used in the treatment of ... $4.95 - Pharma Marketletter - ECNext Article: SYNVISC IMPROVES OSTEOARTHRITIS PAIN. - Biotech … - Jan 1, 2007 SYNVISC IMPROVES OSTEOARTHRITIS PAIN. ... find Biotech Business articles. Genzyme Corporation (NASDAQ:GENZ), Cambridge, Mass. has announced that preliminary ... Pay-Per-View - Biotech Business - HighBeam Research Genzyme Launches Its In Step Program for St. Louis-Area Arthritis … - Sep 20, 2005 Synvisc(R) is a viscosupplementation treatment that restores the properties ... Synvisc is not a drug. It is made from a substance that is found in normal ... RedOrbit Genzyme Announces Results Of Clinical Trial Of Hylastan - Jul 6, 2007 Genzyme has submitted an application to the FDA for Synvisc-One, ... Results from the successful pivotal study of Synvisc-One were presented last month at ... Medical News Today - Medical News Today (press release) … Release: Genzyme Receives European Approval for Synvisc(R) In... - Oct 2, 2006 Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Loislaw Federal District Court Opinions - I-MED PHARMA INC. v. … - Jun 9, 2008 Those products include Synvisc and information related to Synvisc ... Defendants allege that including Synvisc would: (1) "expand discovery to nearly every ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw … & Finance; Genzyme completes purchase of Synvisc sales and... - Feb 3, 2005 2005 FEB 3 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. (GENZ) announced that it has completed the transaction to buy back the sales and marketing rights to ... Pay-Per-View - Women's Health Weekly - Factiva, from Dow Jones … Release: Genzyme Files for European Approval of Synvisc(R) In... - Aug 11, 2006 Genzyme Files for European Approval of Synvisc(R) In Ankle and Shoulder Indications. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Genzyme Launches 'In Step With SYNVISC' Website to Help Sufferers … - Jun 7, 2006 CAMBRIDGE, Mass., June 7 /PRNewswire-FirstCall/ -- Osteoarthritis plagues millions of people, yet often remains undiagnosed until the condition reaches its ... ThomasNet Industrial News Room - ThomasNet Industrial News Room (press... … & Finance; Genzyme completes purchase of Synvisc sales and... - Jan 31, 2005 2005 JAN 31 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. (GENZ) announced that it has completed the transaction to buy back the sales and marketing rights ... Pay-Per-View - Pain & Central Nervous System Week - Factiva, from Dow Jones … Demonstrates One Administration of Synvisc Improves Osteoarthritis... - Nov 30, 2006 Study Demonstrates One Administration of Synvisc Improves Osteoarthritis Pain. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Code and Reimbursement Rate for Synvisc. - PR Newswire | HighB - Dec 15, 2006 PMA) application supplement for Synvisc-One, an alternative treatment ... Genzyme is seeking the same indication for Synvisc-One that is currently ... time. ... Pay-Per-View - PR Newswire - HighBeam Research … : Genzyme Receives FDA Response Letter on Synvisc-One(TM). - PR … - Nov 13, 2007 Genzyme Receives FDA Response Letter on Synvisc-One(TM). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Loislaw Federal District Court Opinions - I-MED PHARMA INC. v. … - Aug 19, 2008 In a footnote, she stated that because Synvisc is not a viscoelastic product for ... In her opinion, Judge Salas mentioned Synvisc only once in a footnote, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw … & Finance; Genzyme completes purchase of Synvisc sales and... - Feb 6, 2005 2005 FEB 6 - (NewsRx.com & NewsRx.net) -- Genzyme Corp. (GENZ) announced that it has completed the transaction to buy back the sales and marketing rights to ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones … (GENZ) Says Positive Data Presented From Independent Study of Synvis... - Jun 23, 2006 As reported at the conference, both treatment groups (3 weekly injections of Synvisc or 5 weekly injections of Hyalgan) experienced pain reduction. ... StreetInsider.com - StreetInsider.com (subscription) … (TM) Has Greater Tolerability Compared to Synvisc(R) for Osteoarthri... - Feb 13, 2006 EUFLEXXA(TM) also showed a significant advantage over Synvisc in the number of joint effusions ... Synvisc is a registered trademark of Genzyme Corporation. ... $4.95 - PR Newswire - ECNext Granulomatous Inflammation After Hylan GF 20 Viscosupplementation of ... - Jul 1, 2006 The material, possibly cartilage, could not have been Synvisc because the patient had never been treated with viscosupplementation (hematoxylin and eosin ... Journal of Bone and Joint Surgery - Journal of Bone and Joint Surgery... Q3 2006 Genzyme Corporation Earnings Conference Call - Final. - Oct 12, 2006 And that was Synvisc. Synvisc came in lower than our expectations and there ... Synvisc is a very, very strong product in a very interesting market that has ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Press Release: Genzyme Announces Results of Clinical Trial of... - Jul 5, 2007 Genzyme has submitted an application to the FDA for Synvisc-One, ... Results from the successful pivotal study of Synvisc-One were presented last month at ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Boston Business Journal Bars Ad That Calls Effectivenes... - Feb 17, 2005 Research has shown that Synvisc may be no more effective than a dummy drug in ... In 2003, Synvisc was Genzyme's third highest revenue-generating product ... Pay-Per-View - PR Newswire - HighBeam Research TRY PHYSICAL THERAPY ON KNEE - Jul 12, 2006 Hyalgan and Synvisc work like high-grade oils for smooth joint motion. Cortisone shots also bring relief. Try hot packs on your knee. ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Peace Pilgrim II: Driving across America in a wheelchair? - Dec 6, 2008 No wonder everyone involved loves SynVisc! Yesterday I went and had my knees acupunctured. They feel better already. I think I'm actually going to be able ... OpEdNews ALSO NOTED: Europe expands Synvisc approval; FDA issues " … - Oct 1, 2006 ...> European regulators have agreed to expand the approval of Genzyme's Synvisc to include osteoarthritis of the ankle and shoulder. Report ... FierceBiotech Genzyme Reports Significant Earnings Growth in Second Quarter - Jul 26, 2007 ...--Launch Synvisc-Oneâ„¢, an investigational combined-dose regimen of Synvisc® ... The company has submitted US and European applications for Synvisc-One, ... webwire.com International Approvals: Champix, Synvisc, Glivec - Oct 9, 2006 October 9, 2006 — The European Commission has approved varenicline tartrate for use as an aid to smoking cessation treatment in adults; ... Medscape … Code and Reimbursement Rate for Synvisc and Illumina Operating... - Dec 18, 2006 ...(Nasdaq: GENZ) recently announced that Synvisc (hylan GF 20), a market- leading viscosupplement used to treat pain due to osteoarthritis of the knee, ... Free with registration - M2 Presswire - AccessMyLibrary.com USA pharma: FDA advisers back new version of Genzyme's knee-pain … - Dec 11, 2008 ...s Synvisc-One, an investigational injectable product intended to relieve pain ... While the panel's backing of Synvisc-One was important for Genzyme's ... $34.00 - EIU Country Analysis - Alacra Store Synvisc injection treatments deemed beneficial in hip OA.( … - Dec 15, 2005 Synvisc injection treatments deemed beneficial in hip OA.(Musculoskeletal Disorders)(osteoarthritis) ... find Family Practice News articles. Pay-Per-View - Family Practice News - HighBeam Research Synvisc injection treatments deemed beneficial in hip OA.( … - Dec 15, 2005 VIENNA -- Ultrasound-guided intraarticular injection of hylan GF 20 (Synvisc) in patients with hip osteoarthritis is safe, well tolerated, and results in ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones Genzyme files in EU for expanded Synvisc label. - Aug 21, 2006 US biotechnology major Genzyme has filed with the European Union health care authority an application to expand the CE mark for Synvisc (hylan GF 20) to ... $4.95 - Pharma Marketletter - ECNext … Code and Reimbursement Decision for Synvisc. - PR Newswire | HighB - Oct 30, 2006 This decision specifically impacts Synvisc(R) (hylan G-F 20), ... Article: Separate Medicare Code and Reimbursement Rate for Synvisc ... ... Pay-Per-View - PR Newswire - HighBeam Research Event Brief of Q4 2006 Genzyme Corporation Earnings Conference Call -... - Feb 14, 2007 ANN MERRIFIELD: On Synvisc 2, we would hope to gain approval such that we launch in the U countries in fourth quarter this year and again approval by year ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … Release: Genzyme Launches 'In Step With SYNVISC' Website to Help … - Jun 7, 2006 Genzyme Launches 'In Step With SYNVISC' Website to Help Sufferers with Osteoarthritis. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Code and Reimbursement Rate for Synvisc and Illumina Operating - Dec 18, 2006 ...(Nasdaq: GENZ) recently announced that Synvisc (hylan G-F 20), a market- leading viscosupplement used to treat pain due to osteoarthritis of the knee, ... Pay-Per-View - M2 Presswire - HighBeam Research Genzyme says Synvisc-One US approval will be delayed til 2nd-qtr 2008. - Nov 19, 2007 USA-based biotechnology major Genzyme has received a letter from the Food and Drug Administration requesting additional analyses and data regarding the ... $4.95 - Pharma Marketletter - ECNext … efficacy of viscosupplementation and Synvisc and Keryx announces … - May 9, 2005 Results reaffirm efficacy of viscosupplementation and Synvisc and Keryx announces positive interim results from Phase 2 clinical study for KRX-101. from M2 ... Pay-Per-View - M2 Presswire - HighBeam Research Genzyme completes buyback of Synvisc.(Brief Article) - Jan 17, 2005 USA-based biotechnology group Genzyme Corp says it has completed the repurchase of sales and marketing rights to Synvisc (hylan GF 20) in the USA and ... $4.95 - Pharma Marketletter - ECNext … efficacy of viscosupplementation and Synvisc and Keryx announces … - May 9, 2005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Genzyme Corp. (Nasdaq: GENZ) announced Thursday that a ... $4.95 - M2 Presswire - ECNext Article: Synvisc injections are reported beneficial in hip osteoarthri... - Sep 15, 2005 Synvisc injections are reported beneficial in hip osteoarthritis.(Rheumatology) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Genzyme Corp acquires Wyeth- Sales,Marketing Rights from Wyeth - … - Jan 6, 2005 US - Genzyme Corp acquired the sales and marketing rights to Synvisc (R) (hylan GF ##) from Wyeth, a manufactrurer of pharmaceutical products, for $### mil. Pay-Per-View - deals - Alacra Store … Code and Reimbursement Rate for Synvisc Retained by Genzyme. - M2 ... - Dec 15, 2006 Separate Medicare Code and Reimbursement Rate for Synvisc Retained by Genzyme. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research Q4 2004 Genzyme Corporation Earnings Conference Call - Final. - Feb 17, 2005 We think very highly of the opportunity in Synvisc and I think we will be able to show some of that impact during the year. The other important structural ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Genzyme Launches Its ''In Step'' Program for Cleveland-Area Arthritis... - Oct 17, 2005 Genzyme's SYNVISC(R) Offers Non-Pill Alternative For Relief from ... Synvisc(R) is a viscosupplementation treatment that restores the properties of the ... $4.95 - Business Wire - ECNext Genzyme Launches Its ''In Step'' Program for Miami-Area Osteoarthritis... - Nov 14, 2005 Synvisc(R) is a viscosupplementation treatment that restores the properties ... Synvisc is not a drug. It is made from a substance that is found in normal ... RedOrbit Ferring Pharmaceuticals Announces Launch of EUFLEXXA(TM) for … - Nov 14, 2005 EUFLEXXA(TM) also showed a significant advantage over Synvisc in the number of patients ... Derived through bacterial fermentation **Synvisc is a registered ... RedOrbit Report from Europe - Aug 18, 2006 ..."Our filing in Europe for approval of Synvisc in the ankle and shoulder ... "With approval in the ankle and shoulder, Synvisc will be one of the few ... Free with registration - Medical Device Week - AccessMyLibrary.com Lewis v. Termeer, No. 03 Civ. 4014 (SDNY 08/03/2006) - Aug 3, 2006 Defendants also failed to disclose that the Biosurgery Division had terminated its French distributor in order to distribute Synvisc directly in France ... $2.95 - U.S. District Court, Southern District... - VersusLaw … Ad That Calls Effectiveness of Genzyme's Osteoarthritis Drug Synvis... - Feb 17, 2005 Research has shown that Synvisc may be no more effective than a dummy drug in ... In 2003, Synvisc was Genzyme's third highest revenue-generating product ... $4.95 - PR Newswire - ECNext Press Release: Ferring Pharmaceuticals Announces Launch of … - Nov 14, 2005 EUFLEXXA(TM) also showed a significant advantage over Synvisc in the number of ... Synvisc: more patients treated with EUFLEXXA(TM) were symptom-free (p=0 . ... Pay-Per-View - PR Newswire - HighBeam Research Event Brief of Q1 2006 Genzyme Corporation Earnings Conference Call -... - Apr 19, 2006 Synvisc is the other product that was a little less than expected, up 21% YtoY. 1. ... Synvisc 2 and hylastan, which were follow-on programs. 1. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Event Brief of Q3 2006 Genzyme Corporation Earnings Conference Call -... - Oct 1, 2006 Performance of Synvisc: 1. Synvisc came in lower than expectations in 3Q06. ... With Synvisc 2, this will be reduced to a single injection, which will: 1. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Colorado Industrial Claim Appeals Office Decisions - IN RE SANCHEZ v.... - Oct 20, 2006 Dr. Sanderford recommended the claimant consider Synvisc injections and Dr. Smith ... Dr. Sanderford concurred in the recommendation for Synvisc injections. ... Pay-Per-View - Colorado Industrial Claim Appeals... - Loislaw Boston Globe, The : BUSINESS IN BRIEF - Dec 6, 2008 Genzyme Inc.'s new version of its Synvisc injection was better than a placebo ... The new product, Synvisc-One, requires a single shot to ease knee pain for ... $2.95 - Boston Globe - NewsBank AG fines delivery company for misclassifying drivers - Dec 20, 2007 Genzyme Corp. won European approval for a one-shot version of Synvisc, ... An existing version of Synvisc requires three injections given a week apart, ... Boston Globe Files show secret Genzyme plan to regain shares cheaply - Sep 10, 2007 The attraction was Synvisc, a promising material that could be injected into ... In early 2003, Genzyme made public that the US distributor of Synvisc was ... Boston Globe Loislaw Federal District Court Opinions - CARDIN v. HARTFORD LIFE & … - Apr 14, 2005 On September 14, 1999, Dr. Maurer began injecting Cardin with Synvisc in ... On April 28, 2000, Dr. Maurer recommended another series of Synvisc injections. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw North Carolina Workers' Compensation Decisions - HART v. SERVICE … - Sep 27, 2007 Dr. Barron suggested that plaintiff was a good candidate for Synvisc and should follow up with Dr. Maitra to continue with the plan for Synvisc. 12. ... Pay-Per-View - North Carolina Workers' Compensation... - Loislaw Loislaw Federal District Court Opinions - LEWIS v. TERMEER (SDNY … - Aug 3, 2006 Internally, Genzyme merged Biomatrix's assets (which included Synvisc, a "blockbuster" medical product that was used to treat osteoarthritis) with those of ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Perales v. Astrue, No. CV 07-908 JAP/RLP (DNM 06/10/2008) - Jun 10, 2008 Plaintiff received the Synvisc injections in June 2006 but they did not relieve his pain. (Tr. 277-279). Dr. Sacoman advised giving the injections more time ... $2.95 - U.S. District Court, District of New... - VersusLaw |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |